Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2013
Reply to R.L. Olin et al
Massimo Federico, Alessandra Dondi
Journal of Mid-Life Health
|
March 28, 2014
Conservative treatment of a femoral neck fracture following nail removal
Claudio Legnani, Alessandra Dondi, Luca Pietrogrande
Expert Opinion on Investigational Drugs
|
March 26, 2014
The potential of pralatrexate as a treatment of peripheral T-cell lymphoma
Alessandra Dondi, Alessia Bari, Samantha Pozzi, et al.
Journal of the American Podiatric Medical Association
|
February 13, 2015
Treatment of bone marrow edema of the talus with pulsed electromagnetic fields: outcomes in six patients
Nicolò Martinelli, Alberto Bianchi, Elena Sartorelli, et al.
Clinical Lymphoma & Myeloma
|
December 3, 2009
The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphoma
Paolo G Gobbi, Vittorio Rosti, Francesco Valentino, et al.
British Journal of Haematology
|
March 31, 2015
Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi
Luigi Marcheselli, Alessia Bari, Antonella Anastasia, et al.
Leukemia & Lymphoma
|
December 30, 2009
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi
Donato Mannina, Stefano Luminari, Alessandra Dondi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 10, 2010
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)
Nicola Di Renzo, Antonella Montanini, Donato Mannina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2013
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi
Massimo Federico, Stefano Luminari, Alessandra Dondi, et al.
American Journal of Hematology
|
October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi
Giuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2013
Reply to R.L. Olin et al
Massimo Federico, Alessandra Dondi
Journal of Mid-Life Health
|
March 28, 2014
Conservative treatment of a femoral neck fracture following nail removal
Claudio Legnani, Alessandra Dondi, Luca Pietrogrande
Expert Opinion on Investigational Drugs
|
March 26, 2014
The potential of pralatrexate as a treatment of peripheral T-cell lymphoma
Alessandra Dondi, Alessia Bari, Samantha Pozzi, et al.
Journal of the American Podiatric Medical Association
|
February 13, 2015
Treatment of bone marrow edema of the talus with pulsed electromagnetic fields: outcomes in six patients
Nicolò Martinelli, Alberto Bianchi, Elena Sartorelli, et al.
Clinical Lymphoma & Myeloma
|
December 3, 2009
The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphoma
Paolo G Gobbi, Vittorio Rosti, Francesco Valentino, et al.
British Journal of Haematology
|
March 31, 2015
Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi
Luigi Marcheselli, Alessia Bari, Antonella Anastasia, et al.
Leukemia & Lymphoma
|
December 30, 2009
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi
Donato Mannina, Stefano Luminari, Alessandra Dondi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 10, 2010
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)
Nicola Di Renzo, Antonella Montanini, Donato Mannina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2013
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi
Massimo Federico, Stefano Luminari, Alessandra Dondi, et al.
American Journal of Hematology
|
October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi
Giuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.
Page
of 2